Cutter & Co Brokerage’s Bristol-Myers Squibb BMY Stock Holding History

Cutter & Co Brokerage’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,056	Closed	-$1.04M	–	22
2025 Q1	$1.04M	Buy	17,056 +1,262	+8%	+$73.6K	0.25%	64
2024 Q4	$893K	Sell	15,794 -3,114	-16%	-$174K	0.22%	68
2024 Q3	$978K	Sell	18,908 -313	-2%	-$14.7K	0.22%	69
2024 Q2	$798K	Buy	19,221 +460	+2%	+$20.6K	0.19%	70
2024 Q1	$1.02M	Sell	18,761 -1,106	-6%	-$56.3K	0.25%	63
2023 Q4	$1.02M	Sell	19,867 -2,522	-11%	-$132K	0.28%	65
2023 Q3	$1.3M	Sell	22,389 -577	-3%	-$35.4K	0.38%	51
2023 Q2	$1.47M	Buy	22,966 +1,580	+7%	+$106K	0.43%	48
2023 Q1	$1.48M	Sell	21,386 -44	-0.2%	-$3.1K	0.46%	50
2022 Q4	$1.54M	Sell	21,430 -784	-4%	-$59.1K	0.52%	44
2022 Q3	$1.58M	Buy	22,214 +308	+1%	+$22.3K	0.59%	41
2022 Q2	$1.69M	Sell	21,906 -28,949	-57%	-$2.2M	0.58%	40
2022 Q1	$3.71M	Sell	50,855 -3,772	-7%	-$253K	1.11%	24
2021 Q4	$3.41M	Buy	54,627 +1,040	+2%	+$61K	0.93%	28
2021 Q3	$3.17M	Buy	53,587 +82	+0.2%	+$5.4K	0.76%	38
2021 Q2	$3.58M	Buy	53,505 +1,913	+4%	+$125K	0.82%	38
2021 Q1	$3.26M	Sell	51,592 -1,878	-4%	-$117K	0.8%	39
2020 Q4	$3.32M	Buy	53,470 +1,526	+3%	+$93.8K	0.87%	33
2020 Q3	$3.13M	Sell	51,944 -621	-1%	-$37.4K	0.93%	28
2020 Q2	$3.09M	Buy	52,565 +3,879	+8%	+$232K	1.01%	27
2020 Q1	$2.71M	Buy	48,686 +11,493	+31%	+$702K	1.02%	32
2019 Q4	$2.39M	Buy	37,193 +387	+1%	+$22.2K	0.84%	36
2019 Q3	$1.87M	Buy	36,806 +1,239	+3%	+$58.2K	0.6%	44
2019 Q2	$1.61M	Buy	35,567 +1,518	+4%	+$70.7K	0.51%	55
2019 Q1	$1.62M	Sell	34,049 -1,032	-3%	-$51.4K	0.46%	52
2018 Q4	$1.82M	Sell	35,081 -626	-2%	-$33.6K	0.69%	41
2018 Q3	$2.22M	Buy	35,707 +984	+3%	+$58.4K	0.76%	36
2018 Q2	$1.92M	Buy	34,723 +4,242	+14%	+$229K	0.74%	39
2018 Q1	$1.93M	Buy	30,481 +1,710	+6%	+$110K	0.76%	36
2017 Q4	$1.76M	Sell	28,771 -1,767	-6%	-$111K	0.72%	40
2017 Q3	$1.95M	Buy	30,538 +1,085	+4%	+$63.4K	0.77%	37
2017 Q2	$1.64M	Buy	29,453 +2,114	+8%	+$115K	0.64%	42
2017 Q1	$1.49M	Buy	27,339 +20,715	+313%	+$1.14M	0.61%	48
2016 Q4	$387K	Buy	6,624 +300	+5%	+$16.4K	0.16%	132
2016 Q3	$341K	Sell	6,324 -19,342	-75%	-$1.24M	0.15%	137
2016 Q2	$1.89M	Buy	25,666 +4,822	+23%	+$341K	0.81%	37
2016 Q1	$1.33M	Buy	20,844 +298	+1%	+$18.8K	0.62%	47
2015 Q4	$1.41M	Buy	20,546 +2,229	+12%	+$147K	0.66%	46
2015 Q3	$1.08M	Hold	18,317	–	–	0.53%	58
2015 Q2	$1.22M	Hold	18,317	–	–	0.49%	64
2015 Q1	$1.18M	Buy	18,317 +949	+5%	+$59.4K	0.48%	66
2014 Q4	$1.02M	Hold	17,368	–	–	0.39%	75
2014 Q3	$889K	Buy	17,368 +38	+0.2%	+$1.9K	0.34%	91
2014 Q2	$841K	Sell	17,330 -40	-0.2%	-$1.97K	0.31%	94
2014 Q1	$902K	Buy	17,370 +219	+1%	+$11.7K	0.36%	86
2013 Q4	$912K	Buy	17,151 +2,671	+18%	+$136K	0.42%	71
2013 Q3	$670K	Sell	14,480 -68	-0.5%	-$2.98K	0.3%	97
2013 Q2	$650K	Buy	+14,548	New	+$632K	0.31%	92

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutter & Co Brokerage's BMY Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 17,056 shares — an estimated $1.04M sold.

Cutter & Co Brokerage first reported a position in BMY in Q2 2013 and held it in 48 quarters. The position peaked at $3.71M in Q1 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Cutter & Co Brokerage reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Cutter & Co Brokerage sold 17,056 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.04M.
Cutter & Co Brokerage first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 48 quarters.
Cutter & Co Brokerage's Bristol-Myers Squibb position peaked at $3.71M in Q1 2022.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.